Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial

Nikolaus Marx, John E. Deanfield, Johannes F.E. Mann, Rosario Arechavaleta, Stephen C. Bain, Harpreet S. Bajaj, Katrine Bayer Tanggaard, Andreas L. Birkenfeld, John B. Buse, Zaklina Davicevic-Elez, Cyrus Desouza, Scott S. Emerson, Mads D.M. Engelmann, G. Kees Hovingh, Silvio E. Inzucchi, Pardeep S. Jhund, Sharon L. Mulvagh, Rodica Pop-Busui, Neil R. Poulter, Søren Rasmussen, Shih-Te Tu, Darren K. McGuire, Unknown

Open source

DOI: 10.1161/circulationaha.125.074545
Published: 2025-06-10
Container: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/circulationaha.125.074545,
  title = {Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial},
  author = {Nikolaus Marx and John E. Deanfield and Johannes F.E. Mann and Rosario Arechavaleta and Stephen C. Bain and Harpreet S. Bajaj and Katrine Bayer Tanggaard and Andreas L. Birkenfeld and John B. Buse and Zaklina Davicevic-Elez and Cyrus Desouza and Scott S. Emerson and Mads D.M. Engelmann and G. Kees Hovingh and Silvio E. Inzucchi and Pardeep S. Jhund and Sharon L. Mulvagh and Rodica Pop-Busui and Neil R. Poulter and Søren Rasmussen and Shih-Te Tu and Darren K. McGuire and Unknown},
  year = {2025},
  journal = {Circulation},
  doi = {10.1161/circulationaha.125.074545},
  url = {https://doi.org/10.1161/circulationaha.125.074545}
}

RIS

TY  - JOUR
TI  - Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
AU  - Nikolaus Marx
AU  - John E. Deanfield
AU  - Johannes F.E. Mann
AU  - Rosario Arechavaleta
AU  - Stephen C. Bain
AU  - Harpreet S. Bajaj
AU  - Katrine Bayer Tanggaard
AU  - Andreas L. Birkenfeld
AU  - John B. Buse
AU  - Zaklina Davicevic-Elez
AU  - Cyrus Desouza
AU  - Scott S. Emerson
AU  - Mads D.M. Engelmann
AU  - G. Kees Hovingh
AU  - Silvio E. Inzucchi
AU  - Pardeep S. Jhund
AU  - Sharon L. Mulvagh
AU  - Rodica Pop-Busui
AU  - Neil R. Poulter
AU  - Søren Rasmussen
AU  - Shih-Te Tu
AU  - Darren K. McGuire
AU  - Unknown
PY  - 2025
JO  - Circulation
DO  - 10.1161/circulationaha.125.074545
UR  - https://doi.org/10.1161/circulationaha.125.074545
ER  -

APA

Marx, N., Deanfield, J. E., Mann, J. F., Arechavaleta, R., Bain, S. C., Bajaj, H. S., Tanggaard, K. B., Birkenfeld, A. L., Buse, J. B., Davicevic-Elez, Z., Desouza, C., Emerson, S. S., Engelmann, M. D., Hovingh, G. K., Inzucchi, S. E., Jhund, P. S., Mulvagh, S. L., Pop-Busui, R., Poulter, N. R., Rasmussen, S., Tu, S., McGuire, D. K., & Unknown (2025). Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial. Circulation. https://doi.org/10.1161/circulationaha.125.074545

Source records

crossref · retrieved 2026-09-26T18:17:41.392Z